Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics Regains Nasdaq Compliance

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics has regained compliance with a Nasdaq rule that its stock meet a minimum $1 share price and will remain listed on the exchange, it announced after the close of the market on Thursday.

The company said that it has received notice from Nasdaq that it will continue being listed on the Nasdaq Capital Market under ticker symbol "ROSGD" through Aug. 3, then revert back to ticker symbol "ROSG" on Aug. 4.

Nasdaq rules stipulate that in order to be traded on its Capital Market, a company's stock must have a closing bid price of at least $1 for 10 consecutive trading days. Rosetta Genomics had been given until Aug. 8 to satisfy the condition.

Earlier this month, the Israeli microRNA-based molecular diagnostics company underwent a one-for-four reverse stock split to satisfy the requirement.

At the close of the market on Thursday, shares of Rosetta Genomics were down 6 percent at $1.50.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.